← Back to headlines
Bioarctic Leads Alzheimer's Treatment Research, Proposes Dividend
Swedish company Bioarctic, originally an academic research project, has revolutionized Alzheimer's disease treatment and is now proposing a dividend after achieving over 1 billion SEK in net profit.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.



